Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19+ B lymphocytes in the peripheral blood

Jeffrey D. McBride, Xiaochen Liu, William L. Berry, Ralf Janknecht, Rui Cheng, Kelu Zhou, Evangelos V Badiavas, Jian xing Ma

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Members of the family of serine proteinase inhibitors, such as kallistatin, have been shown to inhibit canonical Wnt-TCF/LEF-β-catenin signaling via their interactions with the Wnt co-receptor LRP6. Yet the effects of transgenic overexpression of anti-Wnt serpins on hematopoiesis and lymphopoiesis are not well known. We studied the effects of human kallistatin (SERPINA4) on Wnt reporter activity in various cell types throughout the hematopoietic system and associated impacts on circulating white blood cell profiles. Transgenic overexpression of kallistatin suppressed Wnt-TCF/LEF-β-catenin signaling in bone marrow, as demonstrated using a Wnt reporter mouse. Further, kallistatin overexpression and treatment were associated with reduced Wnt-TCF/LEF-β-catenin activity in CD34+ c-kit+ bone marrow cells and CD19+ B lymphocytes, with reduced levels of these populations in bone marrow and peripheral circulation, respectively. The presence of CD3+CD4+, CD3+CD8+, and CD3 NK1.1+ T lymphocytes were not significantly affected. Our data suggest that overexpression of kallistatin interferes with lymphopoiesis, ultimately impacting the level of circulating CD19+ B lymphocytes.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalInternational Journal of Hematology
DOIs
StateAccepted/In press - Mar 15 2017

Fingerprint

B-Lymphocytes
Catenins
Lymphopoiesis
Wnt Receptors
Bone Marrow
Serpins
Hematopoietic System
Serine Proteinase Inhibitors
Hematopoiesis
Bone Marrow Cells
Leukocytes
kallistatin
T-Lymphocytes
Population

Keywords

  • Bone marrow
  • Hematopoiesis
  • Lymphocyte
  • Serpin
  • Stem cell
  • Wnt

ASJC Scopus subject areas

  • Hematology

Cite this

Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19+ B lymphocytes in the peripheral blood. / McBride, Jeffrey D.; Liu, Xiaochen; Berry, William L.; Janknecht, Ralf; Cheng, Rui; Zhou, Kelu; Badiavas, Evangelos V; Ma, Jian xing.

In: International Journal of Hematology, 15.03.2017, p. 1-10.

Research output: Contribution to journalArticle

McBride, Jeffrey D. ; Liu, Xiaochen ; Berry, William L. ; Janknecht, Ralf ; Cheng, Rui ; Zhou, Kelu ; Badiavas, Evangelos V ; Ma, Jian xing. / Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19+ B lymphocytes in the peripheral blood. In: International Journal of Hematology. 2017 ; pp. 1-10.
@article{888600658c974f1880c7a64d4186960f,
title = "Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19+ B lymphocytes in the peripheral blood",
abstract = "Members of the family of serine proteinase inhibitors, such as kallistatin, have been shown to inhibit canonical Wnt-TCF/LEF-β-catenin signaling via their interactions with the Wnt co-receptor LRP6. Yet the effects of transgenic overexpression of anti-Wnt serpins on hematopoiesis and lymphopoiesis are not well known. We studied the effects of human kallistatin (SERPINA4) on Wnt reporter activity in various cell types throughout the hematopoietic system and associated impacts on circulating white blood cell profiles. Transgenic overexpression of kallistatin suppressed Wnt-TCF/LEF-β-catenin signaling in bone marrow, as demonstrated using a Wnt reporter mouse. Further, kallistatin overexpression and treatment were associated with reduced Wnt-TCF/LEF-β-catenin activity in CD34+ c-kit+ bone marrow cells and CD19+ B lymphocytes, with reduced levels of these populations in bone marrow and peripheral circulation, respectively. The presence of CD3+CD4+, CD3+CD8+, and CD3− NK1.1+ T lymphocytes were not significantly affected. Our data suggest that overexpression of kallistatin interferes with lymphopoiesis, ultimately impacting the level of circulating CD19+ B lymphocytes.",
keywords = "Bone marrow, Hematopoiesis, Lymphocyte, Serpin, Stem cell, Wnt",
author = "McBride, {Jeffrey D.} and Xiaochen Liu and Berry, {William L.} and Ralf Janknecht and Rui Cheng and Kelu Zhou and Badiavas, {Evangelos V} and Ma, {Jian xing}",
year = "2017",
month = "3",
day = "15",
doi = "10.1007/s12185-017-2205-5",
language = "English (US)",
pages = "1--10",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19+ B lymphocytes in the peripheral blood

AU - McBride, Jeffrey D.

AU - Liu, Xiaochen

AU - Berry, William L.

AU - Janknecht, Ralf

AU - Cheng, Rui

AU - Zhou, Kelu

AU - Badiavas, Evangelos V

AU - Ma, Jian xing

PY - 2017/3/15

Y1 - 2017/3/15

N2 - Members of the family of serine proteinase inhibitors, such as kallistatin, have been shown to inhibit canonical Wnt-TCF/LEF-β-catenin signaling via their interactions with the Wnt co-receptor LRP6. Yet the effects of transgenic overexpression of anti-Wnt serpins on hematopoiesis and lymphopoiesis are not well known. We studied the effects of human kallistatin (SERPINA4) on Wnt reporter activity in various cell types throughout the hematopoietic system and associated impacts on circulating white blood cell profiles. Transgenic overexpression of kallistatin suppressed Wnt-TCF/LEF-β-catenin signaling in bone marrow, as demonstrated using a Wnt reporter mouse. Further, kallistatin overexpression and treatment were associated with reduced Wnt-TCF/LEF-β-catenin activity in CD34+ c-kit+ bone marrow cells and CD19+ B lymphocytes, with reduced levels of these populations in bone marrow and peripheral circulation, respectively. The presence of CD3+CD4+, CD3+CD8+, and CD3− NK1.1+ T lymphocytes were not significantly affected. Our data suggest that overexpression of kallistatin interferes with lymphopoiesis, ultimately impacting the level of circulating CD19+ B lymphocytes.

AB - Members of the family of serine proteinase inhibitors, such as kallistatin, have been shown to inhibit canonical Wnt-TCF/LEF-β-catenin signaling via their interactions with the Wnt co-receptor LRP6. Yet the effects of transgenic overexpression of anti-Wnt serpins on hematopoiesis and lymphopoiesis are not well known. We studied the effects of human kallistatin (SERPINA4) on Wnt reporter activity in various cell types throughout the hematopoietic system and associated impacts on circulating white blood cell profiles. Transgenic overexpression of kallistatin suppressed Wnt-TCF/LEF-β-catenin signaling in bone marrow, as demonstrated using a Wnt reporter mouse. Further, kallistatin overexpression and treatment were associated with reduced Wnt-TCF/LEF-β-catenin activity in CD34+ c-kit+ bone marrow cells and CD19+ B lymphocytes, with reduced levels of these populations in bone marrow and peripheral circulation, respectively. The presence of CD3+CD4+, CD3+CD8+, and CD3− NK1.1+ T lymphocytes were not significantly affected. Our data suggest that overexpression of kallistatin interferes with lymphopoiesis, ultimately impacting the level of circulating CD19+ B lymphocytes.

KW - Bone marrow

KW - Hematopoiesis

KW - Lymphocyte

KW - Serpin

KW - Stem cell

KW - Wnt

UR - http://www.scopus.com/inward/record.url?scp=85015156540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015156540&partnerID=8YFLogxK

U2 - 10.1007/s12185-017-2205-5

DO - 10.1007/s12185-017-2205-5

M3 - Article

SP - 1

EP - 10

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

ER -